The UK is witnessing a noticeable surge in interest surrounding copyright substances. Beyond the common use of psilocybin and LSD, investigators and adventurers are increasingly exploring less-charted areas, particularly this powerful hallucinogen and the relatively new cannabinoid, cannabigerol.